The medical journal Oncotarget has been becoming more popular over the course of the past couple of years. The medical journal is written in the English language, and it first made its publication in early 2010. The published of Oncotarget is the popular Impact Journals. Oncotarget is sponsored by the Gordon Research Conference.
The main topic of the medical journal Oncotarget is to publish and discuss the latest findings in the field of oncology, hence the name of the journal. Lately, the journal has started accepting submissions n other topics as well. T is stated on the site of the journal that some of the themes which are taken include Neuroscience, all areas of Pharmacology, Metabolism, Endocrinology, Cell Biology, Cardiology, and more.
The medical journal Oncotarget is peer-reviewed which maximizes its accuracy and potential as an active contributor to the medical publication field. Oncotarget publishes interviews with experts from a variety of medical fields as well. Read more about Mikhail at LinkedIn
Oncotarget is edited in chief by two medical experts – Mikhail Blagosklonny and Dr Andrei V. Gudkov Dr Mikhail V. Blagosklonny. In total there are more than two dozen editors who are always making improvements to the journal so that it can be of as high quality as possible. Many of the members of the editorial board of the Oncotarget medical journal have recently been recognised by a number of institutions and organisations. Dr Carlo M. Croce, who is a former Editor-in-Chief of Cancer Research, has published more than 20 papers in the Incototarget and Dr Andrew Schally, who has won a Nobel Prize has published ten papers in the medical journal. Since 2013, several members of the editorial board of Oncotarget have been recognized with a Breakthrough Prize which is an incredible honour for the scientific and medical community. Some of the winners of the coveted Breakthrough Prize are Bert Vogelstein, Michael N. Hall, as well as Stephen J. Elledge.
Dr Mikhail V. Blagosklonny and Dr Andrei Gudkov both occupy positions at the Roswell Park Cancer Institute which is located Buffalo in New York City. Dr Blagosklonny works in the fields of oncology and ageing, and Dr Gudkov operates in the field of molecular biology as well. Visit ResearchGate.Net to learn more about Mikhail’s latest work.